Pilbara Minerals Posts $526M Profit as Lithium Cycle Turns

Pilbara Minerals swung from a A$196 million loss in FY25 to a A$526 million net profit in FY26, on record production, record sales, and a cash balance that now sits at A$2,290 million. In a single fiscal year, the company’s earnings trajectory reversed entirely.

The result lands at a moment when the lithium sector has been searching for hard evidence that the pricing trough is behind it. Pilbara Minerals is Australia’s largest pure-play hard-rock lithium producer, which makes its numbers more than a single-company outcome. They are the closest thing the sector has to a bellwether read on where the cycle stands.

Here is what the production figures, the financial reversal, and the FY27 guidance actually tell you about lithium pricing momentum and Pilbara’s operational position heading into the next fiscal year.

From record output to record cash: Pilbara’s FY26 production story

The production headline is clean. FY26 output at Pilbara Minerals reached 879,500 tonnes of spodumene concentrate (SC5.2), surpassing the company’s own guidance and lifting volumes 17% above the prior year. Sales for the full year followed an identical trajectory, with 891,600 tonnes shipped, also up 17% and a new all-time high for the company.

The fact that sales slightly outpaced production across the full year is the detail worth pausing on. Pilbara was not stockpiling output into a reluctant market. It was moving more product into a market willing to absorb it, which is the more meaningful signal for anyone tracking lithium demand.

The June quarter was where the momentum crystallised. The key figures:

• FY26 production: 879,500 tonnes spodumene concentrate (SC5.2), up 17% year-on-year
• FY26 sales: 891,600 tonnes, up 17% year-on-year, a record
• Q4 FY26 production: 214,300 tonnes
• Q4 FY26 sales: 249,900 tonnes, a quarterly sales record

Production records matter most when they are matched by sales records. The alignment here confirms that operational throughput at the Pilgangoora operation, 100% owned and located in Western Australia’s Pilbara region, converted into real commercial outcomes rather than inventory build.

The Pilgangoora operation has been investing in processing infrastructure beyond conventional spodumene concentration, including mid-stream capabilities that improve product quality and expand the range of offtake structures available to the company.

A $526 million profit where a $196 million loss once sat

A$196 million loss in FY25. A$526 million profit in FY26. The scale of the earnings reversal tells you how much operating leverage sits inside the Pilgangoora model when lithium pricing moves.

Revenue reached A$1,934 million, up 152% year-on-year. Two forces drove it: a 121% rise in the average realised price and the 17% sales volume increase. Price did most of the work, but volume amplified the effect.

The margin picture is where the leverage becomes visible. Underlying EBITDA came in at A$1,137 million, a 59% margin. That tells you Pilgangoora is not just a volume operation. It converts revenue efficiently, which means further price improvement in FY27 would drop through to earnings at an accelerated rate.

The operating leverage embedded in the Pilgangoora model is a function of its fixed cost base relative to marginal production costs, a structure that means each additional tonne of output at current pricing contributes to earnings at a rate significantly above the average.

The June quarter alone generated A$743 million in revenue, up 31% quarter-on-quarter, confirming the momentum was accelerating into the close of the fiscal year.

Pilbara reinstated a fully franked final dividend of 5 cents per share. For investors, the dividend reinstatement is as meaningful as the profit number itself: it is management’s explicit signal that the earnings recovery is durable enough to begin returning capital. All figures remain unaudited; final adjustments are possible.

What the pricing recovery and cost discipline actually looked like quarter by quarter

The full-year average realised price of US$1,488/t captures the total effect: a 121% increase year-on-year. But that annual average masks a story that unfolded in stages, and the quarterly progression is where the pricing recovery becomes convincing.

The March quarter jump of 61% to US$1,867/t was the inflection. The June quarter at US$2,107/t (approximately US$2,415/t on an SC6 basis) confirmed the direction. This is not a single-quarter spike that could reverse. It is a sequential progression with momentum, and that distinction matters when pricing the FY27 outlook.

Cost discipline alongside the price recovery

The rising price curve would mean less if costs were rising alongside it. They were not. Full-year unit operating costs came in at A$569/t FOB, a 9% improvement year-on-year and at the lower end of guidance.

The June quarter unit operating cost of A$616/t FOB was pushed higher by diesel price increases and expenditure tied to the Ngungaju plant recommissioning process. Both are timing items rather than structural cost pressures. Across the full year, volume leverage and cost discipline preserved the margin expansion that pricing delivered.

The combination of a rising price curve and tightening unit costs is the setup that produces sustained earnings growth, not a one-year recovery anomaly.

A$2.29 billion in cash and a production ramp that changes the FY27 equation

By 30 June 2026, Pilbara’s cash balance had grown to A$2,290 million, representing a 135% lift year-on-year and a 57% increase across the June quarter alone. A balance sheet of this scale removes any survival-scenario risk from the investment case.

Net cash of A$1,340 million was supported by total available liquidity of A$2,790 million. A cash position of this scale on a company of Pilbara’s size means it is not just surviving the lithium cycle. It is accumulating the capital to shape the next phase of it, which changes the risk profile materially for investors evaluating the stock.

The P2000 expansion remains the most consequential long-term variable in the Pilgangoora story, with feasibility work targeting approximately two million tonnes per annum capacity that would roughly double the operation’s current scale.

The FY27 guidance confirms the operational step-up:

• Production guidance: 1,030-1,100kt spodumene concentrate, a step-up of approximately 17-25% from the FY26 record
• FOB unit cost guidance: A$575-625/t
• Ngungaju plant: restart commenced post-30 June 2026, progressing on schedule toward steady-state production in early FY27
• P2000 expansion: feasibility work ongoing, targeting approximately 2 million tonnes per annum capacity

The production step-up to over one million tonnes, combined with the cash reserves, means Pilbara is positioned to benefit from any further price recovery without needing to raise capital or constrain operations. Capital allocation optionality sits across organic growth at Pilgangoora, shareholder returns (the reinstated dividend is the first signal), and selective M&A or downstream integration.

What Pilbara’s result signals about where the lithium cycle stands

The individual numbers are now established. What they add up to is the more important read.

Pilbara Minerals operates at a scale and cost position that makes its results a high-conviction signal for the broader lithium sector, not just a single-company outcome. When the largest pure-play hard-rock producer posts record volumes, a 121% price recovery, and a A$2.29 billion cash position, that is data the entire sector prices off.

The recovery is real, but it is still early. The FY26 full-year average realised price of US$1,488/t reflects a year where the first half was still depressed. The June quarter exit price of US$2,107/t is the more forward-relevant number, and it is the one investors should be watching against spot market movements through FY27.

Three variables will determine whether this result was a floor or the beginning of a sustained re-rating:

• Ngungaju ramp: whether the plant reaches steady-state on schedule in early FY27
• Pricing trajectory: whether spot pricing holds above trough levels or continues the sequential improvement seen in the March and June quarters
• P2000 feasibility timeline: whether the expansion study advances to a decision-ready stage, signalling the next leg of production growth

If spot pricing holds or improves through FY27, the earnings leverage from the volume ramp could produce a result materially ahead of FY26. That is the scenario lithium-exposed investors need to consider.

Reading the FY26 result: what holds and what FY27 still needs to prove

Several elements of Pilbara’s position are no longer dependent on further price improvement. The A$2,290 million cash balance (net cash A$1,340 million) removes balance sheet risk. The full-year unit cost of A$569/t FOB confirms cost discipline is not a one-quarter anomaly. The reinstated 5 cents per share fully franked dividend signals that management views the earnings recovery as durable enough to return capital. These are structural positives.

What FY27 still needs to deliver is execution. Ngungaju reaching steady-state on schedule, pricing holding above trough levels, and the P2000 feasibility study advancing to a decision-ready stage are the three variables that will determine whether the recovery deepens or plateaus.

For investors tracking lithium, this result changes what you are monitoring. The question is no longer whether Pilbara can survive a downturn. It is whether the production ramp, capital return programme, and pricing trajectory confirm a sustained growth cycle. FY26 built the base. FY27 is where the thesis gets tested.

For investors tracking the sector beyond a single company, our dedicated guide to ASX lithium stocks covers how Pilbara compares to peers across cost position, resource scale, and exposure to the spodumene pricing cycle.

This article is for informational purposes only and should not be considered financial advice. Investors should conduct their own research and consult with financial professionals before making investment decisions. Past performance does not guarantee future results. Financial projections are subject to market conditions and various risk factors.